43.61 USD
↗ 0.82 (1.92%)AT CLOSE (11:59 AM EDT)
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
KNSANASDAQ • USD
43.89
↗ 0.28 (0.64%)
POST MARKET (AS OF 06:02 PM EDT)
Post Market
AS OF 06:02 PM EDT
43.89
↗ 0.28 (0.64%)
Market: CLOSED
Open?$42.67
High?$44.23
Low?$42.61
Prev. Close?$42.79
Volume?1.3M
Avg. Volume?659.9K
VWAP?$43.44
Rel. Volume?1.96x
Bid / Ask
Bid?$37.06 × 100
Ask?$49.81 × 100
Spread?$12.75
Midpoint?$43.44
Valuation & Ratios
Market Cap?3.3B
Shares Out?46.2M
Float?38.9M
Float %?84.2%
P/E Ratio?55.50
P/B Ratio?5.77
EPS?$0.77
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?3.79Strong
Quick Ratio?3.39Strong
Cash Ratio?1.19Strong
Debt/Equity?0.12Low
ValuationFAIRLY VALUED
Score56/100
P/E?55.5PRICEY▾
P/B?5.77FAIR▾
P/S?4.83FAIR▾
P/FCF?24.0FAIR▾
EV/EBITDA?40.4HIGH▾
EV/Sales?4.69FAIR▾
Returns & Efficiency
ROE?10.4%FAIR▾
ROA?7.7%STRONG▾
Cash Flow & Enterprise
FCF?$136.4M
Enterprise Value?$3.2B
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
Address
105 PICCADILLY, SECOND FLOOR
LONDON, W1J 7NJ
Phone: (781) 431-9100
LONDON, W1J 7NJ
Phone: (781) 431-9100